BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 31646576)

  • 1. LncRNA SAMD12-AS1 down-regulates P53 to promote malignant progression of glioma.
    Yu BX; Zou L; Li S; Du YL
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8456-8467. PubMed ID: 31646576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
    Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
    Tan SF; Ni JX; Xiong H
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA FOXD2-AS1 stimulates glioma progression through inhibiting P53.
    Zhao QS; Ying JB; Jing JJ; Wang SS
    Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4382-4388. PubMed ID: 32373975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA SAMD12-AS1 Promotes the Progression of Gastric Cancer via DNMT1/p53 Axis.
    Lu GH; Zhao HM; Liu ZY; Cao Q; Shao RD; Sun G
    Arch Med Res; 2021 Oct; 52(7):683-691. PubMed ID: 33962804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
    Ma CX; Gao WC; Tian L
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA SAMD12-AS1 promotes cell proliferation and inhibits apoptosis by interacting with NPM1.
    Liu Q; Liu N; Shangguan Q; Zhang F; Chai W; Tong X; Zhao X; Li Z; Qi D; Ye X
    Sci Rep; 2019 Aug; 9(1):11593. PubMed ID: 31406141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
    Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
    Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
    Xu L; Hou TJ; Yang P
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
    Chen AY; Zhang K; Liu GQ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA SAMD12-AS1 Suppresses Proliferation and Migration of Hepatocellular Carcinoma via p53 Signaling Pathway.
    Wang J; Zhou Y; Gu C; Ming F; Zhang Y
    J Oncol; 2022; 2022():9096365. PubMed ID: 36052283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.
    Sun WL; Kang T; Wang YY; Sun JP; Li C; Liu HJ; Yang Y; Jiao BH
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30498093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-374b inhibits migration and invasion of glioma cells by targeting EGFR.
    Pan DS; Cao P; Li JJ; Fan D; Song ZQ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4254-4263. PubMed ID: 31173297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Long Noncoding RNA TP73-AS1 Interacted with miR-124 to Modulate Glioma Growth by Targeting Inhibitor of Apoptosis-Stimulating Protein of p53.
    Xiao S; Wang R; Wu X; Liu W; Ma S
    DNA Cell Biol; 2018 Feb; 37(2):117-125. PubMed ID: 29412778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circ_0005075 stimulates the proliferation and metastasis of glioma via downregulating SIRT1.
    Fang DZ; Wang WJ; Li FY; Liu J; Hui XB; Liu D; Wang XD
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):258-266. PubMed ID: 31957839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-expression of the long non-coding RNA HOTTIP inhibits glioma cell growth by BRE.
    Xu LM; Chen L; Li F; Zhang R; Li ZY; Chen FF; Jiang XD
    J Exp Clin Cancer Res; 2016 Oct; 35(1):162. PubMed ID: 27733185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ-DONSON promotes malignant progression of glioma through modulating FOXO3.
    Zou Z; Dong YS; Liu JM; Zhao ZH; Li G; Liu DD
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):749-757. PubMed ID: 32016978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
    Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4467-4476. PubMed ID: 30058678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.